NO942228L - Ipsapirone drug preparation - Google Patents

Ipsapirone drug preparation

Info

Publication number
NO942228L
NO942228L NO942228A NO942228A NO942228L NO 942228 L NO942228 L NO 942228L NO 942228 A NO942228 A NO 942228A NO 942228 A NO942228 A NO 942228A NO 942228 L NO942228 L NO 942228L
Authority
NO
Norway
Prior art keywords
hours
release
ipsapirone
drug preparation
ipsaplron
Prior art date
Application number
NO942228A
Other languages
Norwegian (no)
Other versions
NO942228D0 (en
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Gunter Schollnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO942228D0 publication Critical patent/NO942228D0/en
Publication of NO942228L publication Critical patent/NO942228L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det blir beskrevet Ipsaplron-legemlddeltllberednlnger med midlere frlglvlngshastlghet mellom 80*/5 timer til 8056/13 timer og en inltiell frlgivingshastighet på mindre enn 35* ipsaplron i de første 2 timene av fri- gi vnlngen. Disse tilberedningene har god biotilgjengelighet og lagerstabilltet, og består av dlsfusjonskontrollerte pellets eller erosjonstabletter med definert virke- stoff -frigi ving.Ipsaplron drug delivery preparations are described with average release rates between 80 * / 5 hours to 8056/13 hours and an initial release rate of less than 35 * ipsaplron in the first 2 hours of release. These preparations have good bioavailability and the storage stack, and consist of dlsfusion controlled pellets or erosion tablets with defined active substance release.

NO942228A 1993-06-15 1994-06-14 Ipsapirone drug preparation NO942228L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (en) 1993-06-15 1993-06-15 Ipsapiron drug preparation

Publications (2)

Publication Number Publication Date
NO942228D0 NO942228D0 (en) 1994-06-14
NO942228L true NO942228L (en) 1994-12-16

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942228A NO942228L (en) 1993-06-15 1994-06-14 Ipsapirone drug preparation

Country Status (16)

Country Link
EP (1) EP0629402A1 (en)
JP (1) JPH06345649A (en)
KR (1) KR950000150A (en)
CN (1) CN1099263A (en)
AU (1) AU6345794A (en)
CA (1) CA2125620A1 (en)
CZ (1) CZ146494A3 (en)
DE (1) DE4319760A1 (en)
FI (1) FI942803A (en)
HU (1) HUT70759A (en)
IL (1) IL109993A0 (en)
NO (1) NO942228L (en)
NZ (1) NZ260732A (en)
PL (1) PL303822A1 (en)
SK (1) SK72494A3 (en)
ZA (1) ZA944187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
WO2000038686A1 (en) * 1998-12-24 2000-07-06 Janssen Pharmaceutica N.V. Controlled release galantamine composition
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
BR112023003572A2 (en) * 2020-09-02 2023-04-04 Beijing Biostar Pharmaceuticals Co Ltd UTIDELONE SOLID ORAL FORMULATION

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59000232D1 (en) * 1989-02-11 1992-09-10 Bayer Ag MEDICINAL PRODUCTS WITH CONTROLLED DELIVERY OF ACTIVE SUBSTANCES.
DD297767A5 (en) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De MEDICINAL PRODUCTS WITH CONTROLLED ACTIVE INGREDIENTS
JPH04360826A (en) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk Controlled release pharmaceutical preparation

Also Published As

Publication number Publication date
ZA944187B (en) 1995-02-08
FI942803A0 (en) 1994-06-13
HU9401771D0 (en) 1994-09-28
CA2125620A1 (en) 1994-12-16
NZ260732A (en) 1996-02-27
EP0629402A1 (en) 1994-12-21
KR950000150A (en) 1995-01-03
AU6345794A (en) 1994-12-22
CN1099263A (en) 1995-03-01
DE4319760A1 (en) 1994-12-22
HUT70759A (en) 1995-10-30
SK72494A3 (en) 1995-04-12
FI942803A (en) 1994-12-16
IL109993A0 (en) 1994-10-07
JPH06345649A (en) 1994-12-20
CZ146494A3 (en) 1995-01-18
PL303822A1 (en) 1995-01-09
NO942228D0 (en) 1994-06-14

Similar Documents

Publication Publication Date Title
CA2327973A1 (en) Storage system for powdered pharmaceuticals, and inhaler equipped with this system
AU6995794A (en) Aspb28 insulin crystals
TR199802034T2 (en) �apraz ba�lant�l� amylose ve hydroxypropylmethylcellulose baz�nda bir ta��y�c� i�eren kontroll� ��z�l�ml� farmas�tik tablet.
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
IT8719064A0 (en) TABLET FOR PHARMACEUTICAL USE SUITABLE FOR THE RELEASE OF ACTIVE SUBSTANCES AT SUBSEQUENT TIMES.
NO953278L (en) Methods for in vivo delivery of biologically active substances and compositions useful for this purpose
AU692430B2 (en) Aqueous pharmaceutical preparations of G-CSF with a long shelf life
NZ511020A (en) Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
WO1994012165A3 (en) Enzyme inhibitors
UA66417C2 (en) Recombinant adenovirus affecting canines, pharmaceutical composition
CA2304808A1 (en) Liquid interferon-.beta. formulations
WO1994013808A3 (en) LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
HUP0103669A2 (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
IE821861L (en) Pharmaceutical compositions
CO5011082A1 (en) DRUG FORMULATION WITH CONTROLLED RELEASE OF ACTIVE SUBSTANCE
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
IT1314185B1 (en) PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION OF SUBSTANCES ACTIVELY SOLUBLE IN AQUEOUS MEDIA
EP0514464A4 (en) Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
NO942228L (en) Ipsapirone drug preparation
AU687623B2 (en) Cell Adhesion peptides for use in modifying mutual adhesion among eukaryotic cells
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
FR2749514B1 (en) TRANSDERMAL SYSTEMS CONTAINING 2 ACTIVE INGREDIENTS IN SEPARATE COMPARTMENTS, THEIR PREPARATION METHOD AND THEIR APPLICATION AS A MEDICAMENT
WO2000063348A3 (en) Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
IT9048066A0 (en) 2- 6, 7-SUSTITUTED AMINOTETRALINES ACTIVE AS IMMUNOMODULANTS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
WO1996015234A3 (en) Lipid-splitting enzyme